Essential microelement contents in the blood plasma of children with biologically inactive growth hormone syndrome
Journal Title: Міжнародний ендокринологічний журнал - Year 2018, Vol 14, Issue 6
Abstract
Background. The purpose was to increase the effectiveness of treatment in children and adolescents with biologically inactive growth hormone syndrome (BIGHS) based on studying the content of essential microelements (EM) in the blood plasma. Materials and methods. The study included 206 children and adolescents with different forms of short stature. Group with BIGHS consisted of 29 children (14.08 %): 21 boys (72.41 %) and 8 girls (27.59 %), with growth retardation from –2.0 to –4.6 SD. The average age of children was 9.01 ± 0.60 years. Diagnosis of BIGHS was confirmed by the presence of normal/elevated growth hormone parameters against the background of stimulation tests, a sharp decrease in the level of insulin-like growth factor-1 (IGF-1), and positive test for growth hormone sensitivity. The microelement status was assessed by determining the levels of EM (zinc, selenium, manganese, chromium, copper) in the blood plasma by X-ray fluorescence spectrometry using the ElvaX-med spectrometer (Ukraine). Plasma levels of IGF-1 were evaluated by immunoradiometric assay (IRMA) using standard IRMA IGF-1 kits (Immunotech® kit, Czech Republic). Results. In the group of children with BIGHS, the levels of zinc and selenium were 0.57 ± 0.04 μg/ml and 0.05 ± 0.01 μg/ml, respectively, that is significantly lower than in the general group of children with short stature (p < 0.001 and p < 0.05, respectively). The average plasma levels of chromium and copper were lower than those in children with other forms of short stature and amounted to 0.040 ± 0.003 μg/ml and 0.79 ± 0.05 μg/ml, respectively, but were significantly lower than in the control group (р < 0.001). The average level of manganese in the blood plasma was 0.06 ± 0.02 μg/ml, which is somewhat lower than in the control group, but not significantly (p > 0.01). Conclusions. Patients with BIGHS were found to have potentially lower levels of zinc, selenium, chromium and copper in the blood plasma. Thus, in our opinion, it is advisable to include the determination of EM levels in a comprehensive examination of children with short stature. When detecting lower levels of EM, a combined treatment with recombinant growth hormone preparations and those containing appropriate EM is recommended that significantly increases the effectiveness of growth-correction therapy.
Authors and Affiliations
N. A. Sprinchuk, V. G. Pakhomova, O. V. Bolshova
Keywords
Related Articles
- EP ID EP412491
- DOI 10.22141/2224-0721.14.6.2018.146062
- Views 73
- Downloads 0
Content of Diabetes-Associated Autoantibodies against Islet Autoantigens (IA-2A, GADA, IAA) and the Level of Different Cytokines in Children and Adolescents on the Pre-Clinical and Early Clinical Stages of Type 1 Diabetes Mellitus Development
The article provides the data on the immunological mechanisms of type 1 diabetes mellitus (T1DM) on the preclinical and early clinical stages of disease formation on the basis of studying the features of T1DM pathogenesi...
New guidelines of the American Diabetes Association 2018 on the diagnosis and treatment of diabetes mellitus
The article considers some aspects of the recently published recommendations of the American Diabetes Association on the diagnosis, prevention and treatment of diabetes mellitus.
Diagnostic Markers and the Method of Predicting Chronic Pancreatitis Development in Patients with Type 2 Diabetes Mellitus
The purpose of the present study was to determine the diagnostic markers and the method of predicting of chronic pancreatitis in type 2 diabetes mellitus patients. Materials and methods. A total of 94 patients (33 males...
Features of pahogocytic activity of monocytes and neutrophils in patients with obesity and ankylosinig spondylitis depending on HLA B27 gene carrier
Background. Ankylosing spondylitis (AS) is a widespread pathology all over the world. The AS prevalence in different countries ranges from 0.2 to 2 %. Usually the disease debuts at the age of 20–40 years, men suffer from...
Diagnosis and treatment of thyrotoxicosis during pregnancy and in the postpartum period. A fragment of 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum
In 2017, the American Thyroid Association (ATA) published the guidelines for the diagnosis and treatment of thyroid diseases during pregnancy and the postpartum period [1]. This is the first review of similar ATA recomme...